Empowering patients through shared knowledge and community-driven health insights.
The information on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
© 2026 MedInfo World. All rights reserved.
Relugolix – Uses, Side Effects, Dosage & Drug Information | MedInfo World | MedInfo World
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Home Active Ingredients Relugolix Relugolix Gonadotropin Releasing Hormone Receptor Antagonist [EPC]
2 Drugs 2 Variants
Category
Gonadotropin Releasing Hormone Receptor Antagonist [EPC]
Gonadotropin Releasing Hormone Receptor Antagonist [EPC]
Important Notice This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Relugolix.
Gonadotropin Releasing Hormone Receptor Antagonists [MoA] Cytochrome P450 3A Inducers [MoA] Cytochrome P450 2B6 Inducers [MoA] Breast Cancer Resistance Protein Inhibitors [MoA] P-Glycoprotein Inhibitors [MoA]
RxCUI
2472783, 2472789, 2556799, 2556800
UNII
P76B05O5V6, CXY7B3Q98Z, 9S44LIC7OJ
Drugs with Relugolix Medications containing this ingredient
1